Search results

Page results

• World’s first COVID-19 vaccine alternating dose study launches at UCLH

  The world’s first COVID-19 vaccine study researching alternating doses and intervals of approved vaccines is taking place at UCLH.

• Cystic fibrosis drug tested to fight inflammation in COVID-19

  Patients with COVID-19 will be given the cystic fibrosis drug ‘Dornase alfa’ to determine if it can help improve survival by reducing excess inflammation in the lungs in a trial at UCLH.

• NEW: Helpful videos about managing common cancer treatment side effects

  Short videos on managing cancer pain, cancer-related fatigue and improving sleep

• Increase in delirium, rare brain inflammation and stroke linked to COVID-19

  Neurological complications of COVID-19 can include delirium, brain inflammation, stroke and nerve damage, finds a new UCL and UCLH-led study.

• New national study on long-term health impacts of COVID-19 launched

  UCLH will be part of a major UK research study looking at the long-term health impacts of COVID-19.

• Haematology and critical care services open in the Grafton Way Building

  The haematology and critical care services in our flagship University College Hospital Grafton Way Building are now open.

• 'Gamechanger' drug for treating obesity cuts body weight by 20%

  In a major study involving UCLH a third of people who took a new drug for treating obesity lost more than one-fifth of their total body weight.

• More than 800 patients seen over ‘super-weekend’ for ENT in North Central London

  More than 800 patients on waiting lists for Ear, Nose and Throat appointments across North Central London seen in two days during ENT surgery ‘super-weekend’

• Loss of smell a ‘highly specific’ indicator of Covid-19, finds UCLH and UCL research

  Acute loss of sense of smell should be considered globally as a criterion for self-isolation, testing, and contact tracing for Covid-19 infection according to researchers at UCLH and UCL.

• Age no criterion for decisions on heart attack treatment, new research finds

  Elderly patients suffering the most common type of heart attack may benefit from more invasive treatment, new research involving UCLH has shown.